Sildenafil Tablet, Film Coated
Product Images NDC 50090-7964

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Sildenafil (NDC 50090-7964). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Lbl500907964)

Sildenafil 100 mg film-coated tablets package label from A-S Medication Solutions, Libertyville, IL. The label includes product and dosage information, storage instructions to keep at 68 to 77 degrees Fahrenheit, and quantity of 10 tablets. NDC 50090-7964-0 is also displayed on the label.*

FDA Label Image

Figure 1 (Sildenafil Fig1)

A line graph depicting mean change from baseline in sitting systolic blood pressure over 24 hours in healthy volunteers. It compares Sildenafil 100 mg to placebo, showing time post dose in hours on the x-axis and systolic blood pressure change (mmHg) on the y-axis, with two distinct trend lines for each group.*

FDA Label Image

Figure 2 (Sildenafil Fig2)

A line graph titled 'Figure 2: Mean Standing Systolic Blood Pressure Change from Baseline' showing changes in systolic blood pressure (SBP) over eight hours postdose. Two data series compare Doxazosin + Placebo and Doxazosin + Sildenafil 25 mg, with the y-axis measuring change in SBP (mmHg) and the x-axis showing time postdose (hours).*

FDA Label Image

Figure 3 (Sildenafil Fig3)

A line graph showing mean standing systolic blood pressure change from baseline over 8 hours postdose. It compares Doxazosin plus Placebo and Doxazosin plus Sildenafil 50 mg groups, illustrating blood pressure changes in mmHg versus time in hours.*

FDA Label Image

Figure 4 (Sildenafil Fig4)

A line graph showing mean standing systolic blood pressure change from baseline over 8 hours post-dosing. The graph compares two groups: one receiving Doxazosin with Sildenafil 100 mg and another receiving Doxazosin with placebo. The y-axis measures blood pressure change in mmHg, and the x-axis shows time after dosing in hours.*

FDA Label Image

Figure 5 (Sildenafil Fig5)

A line graph titled 'Mean Sildenafil Plasma Concentrations in Healthy Male Volunteers' showing plasma concentration (ng/mL) on the y-axis and time post dose (hours) on the x-axis. The graph depicts plasma levels rising sharply to a peak within 1-2 hours after dosing with a commercial tablet, then gradually declining over 24 hours.*

FDA Label Image

Figure 6. Effect Of Sildenafil And Placebo On Maintenance Of Erection By Baseline Score (Sildenafil Fig6)

Two bar charts showing the effect of Sildenafil and placebo on maintenance of erection by baseline score. The top chart represents Sildenafil, and the bottom chart represents placebo. Both charts display percentages of patients at endpoint by baseline score categories from 0 to 5, with multiple bars indicating different score values.*

FDA Label Image

Sildenafile Fig 7 (Sildenafil Fig7)

A vertical bar chart showing the percentage of patients reporting improvement in erections across four treatment groups: Placebo, Sildenafil 25 mg, Sildenafil 50 mg, and Sildenafil 100 mg. The percentage increases with dosage, with Placebo lowest and Sildenafil 100 mg highest, illustrating a dose-dependent response.*

FDA Label Image

Structure (Sildenafil Str)

Chemical structure diagram of the active ingredient Sildenafil, showing its molecular arrangement including various functional groups and ring structures.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.